Glycogen-Dependent Metabolic Reprogramming Regulates Microglial Activation and Dysfunction in Neurodegenerative Disease
McAlister, H.; Merchant, H.; Mitchener, V.; Gatto, N.; Thackray, M.; Blackburn, E.; Shackleton, L.; Gentry, M. S.; Arancibia Carcamo, L.; Lloyd, A. F.
Show abstract
Microglia are central regulators of neuroinflammation in Alzheimers disease (AD), yet how metabolic states modulate function remains unclear. Here we show that microglia from the APPNL-G-F mouse model revealed upregulation of glycolytic enzymes coinciding with onset of microglial activation. Surprisingly, this glycolytic shift occurred alongside reduced expression of glucose transporters, suggesting that extracellular glucose may not be the primary fuel source, implicating glycogenolysis as the potential metabolic driver. Consistent with this, significant microglial glycogen accumulation was noted in late disease, when cells exhibited features of metabolic exhaustion and functional impairment. Pharmacological inhibition of glycogenolysis blunted microglia responses to Abeta aggregates and markedly reduced Abeta uptake, confirming a functional role for glycogen metabolism in shaping microglial states. Together, these findings identify glycogen as a central regulator of microglial metabolic health and function, highlighting glycogen homeostasis as a potential therapeutic target for promoting Abeta clearance and preserving protective microglial functions in AD.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Diabetic phenotype in mouse and humans with β-amyloid pathology reduces the number of microglia around β-amyloid plaques 97%
- A Trem2*R47H mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques 96%
- A Microglial Activity State Biomarker Panel Differentiates Ftd-Granulin And Ad From Control Cases 96%
Similar papers in this journal
- AIBP controls TLR4 inflammarafts and mitochondrial dysfunction in a mouse model of Alzheimer's disease 97%
- 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner 96%
- Astrocytic C-X-C motif chemokine ligand-1 mediates β-amyloid-induced tau mislocalization and synaptotoxicity 96%
Similar papers in this journal
- Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer's disease 95%
- An interim exploratory biomarker analysis of a Phase 2 clinical trial to assess the impact of CT1812 in Alzheimers disease 94%
- Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease 94%
Similar papers in this journal
- Astrocytic uptake of posttranslationally modified amyloid-β leads to endolysosomal system disruption and induction of pro-inflammatory signaling 95%
- Generation of an inducible destabilized-domain Cre mouse line to target disease associated microglia 95%
- Low-grade systemic inflammation stimulates microglial turnover and accelerates the onset of Alzheimer's-like pathology 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.